Fujian Institute of Trational Chiness Medicine
Fuzhou, Fujian, 350003, China
NCT Number: NCT02128009
The miRNA plays an important regulation role in gene expression, and also closely related to bone metabolism. Previous research found that postmenopausal osteoporosis with kidney Yin deficiency syndrome (POP) is associated with CLCF1 gene. This project proposed by bioinformatics prediction CLCF1 targeted regulation of miRNAs, and use the 3 'UTR dual luciferase report system for target validation, aimed at the miRNA levels to explore postmenopausal osteoporosis molecular mechanism with kidney Yin deficiency syndrome.
Looking for future studies?
Notify Me45 year–75 year
Female
Observational
Fuzhou, Fujian, 350003, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Fujian Academy of Traditional Chinese Medicine
Other
Study on the Molecular Mechanism in Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome Based on miRNA Mediated Gene Translation Regulation Function by Targeting CLCF1
Acronym: microRNA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07685392
Accidental Falls, Aged, Exercise Movement Techniques, Bone Diseases
Mexico City, Mexico
View Trial DetailsNCT05405725
Bone Diseases, Bone Diseases, Metabolic
Plovdiv, Bulgaria
View Trial DetailsNCT06079476
Bone Diseases, Bone Diseases, Metabolic
Ahmedabad, Gujarat, India
View Trial DetailsNCT05630768
Bone Diseases, Bone Diseases, Metabolic
Seoul, Seodaemun-gu, South Korea
View Trial Details